Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
46,516,239
-
Share change
-
+2,864,909
-
Total reported value
-
$947,641,508
-
Put/Call ratio
-
74%
-
Price per share
-
$20.37
-
Number of holders
-
210
-
Value change
-
+$64,706,175
-
Number of buys
-
116
-
Number of sells
-
92
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2016
As of 30 Jun 2016 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,516,239 shares of stock of the company.
Largest 10 holders included BlackRock Fund Advisors, Ranger Investment Management, L.P., VANGUARD GROUP INC, GLENMEDE TRUST CO NA, Bank of New York Mellon Corp, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Fiera Capital Corp, Neumeier Poma Investment Counsel LLC, and STATE STREET CORP.
This table shows 210 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.